COVID-19 and Acute Invasive Fungal Rhinosinusitis

Al-Azhar University56 enrolled

Overview

Data for acute invasive rhinosinusitis was obtained from the Otorhinolaryngology departments at our tertiary hospital at the period from January 2017 to December 2020. Then the risk factors of comorbid diseases and fungal types between post-Covid-19 and non-Covid-19 groups regarding the incidence of invasive rhinosinusitis are compared.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Covid19

Interventions

Fungal rhinosinusitisDIAGNOSTIC_TEST

Pathology examination

Eligibility

Sex: ALLMin age: 15 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients of any age and sex. invasive rhinosinusoitis diagnosis based on clinical , endoscopic diagnosis * Positive findings for acute sinusitis on sinus computed tomography (CT) scan in addition to fungal determination by histopathological examination of specimen of affected tissues for detection of the type of fungi. * Positive PCR was confirmed from the patient's files at the isolation hospitals for COVID 19 group. Exclusion Criteria: * Patients who completed management outside our hospital

Outcomes

Primary Outcomes

Fungus detection

Culture and microscopic examination by the light microscope to examine the different types of the fungi using hematoxylin \& eosin stain and Periodic acid-Schiff stain which is positive in fungi

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.